PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
SHEL vs. VRTX
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between SHEL and VRTX is 0.22, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.2

Performance

SHEL vs. VRTX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Shell plc (SHEL) and Vertex Pharmaceuticals Incorporated (VRTX). The values are adjusted to include any dividend payments, if applicable.

-20.00%-15.00%-10.00%-5.00%0.00%5.00%AugustSeptemberOctoberNovemberDecember2025
-7.49%
-15.81%
SHEL
VRTX

Key characteristics

Sharpe Ratio

SHEL:

0.50

VRTX:

-0.17

Sortino Ratio

SHEL:

0.76

VRTX:

-0.07

Omega Ratio

SHEL:

1.10

VRTX:

0.99

Calmar Ratio

SHEL:

0.53

VRTX:

-0.18

Martin Ratio

SHEL:

1.39

VRTX:

-0.51

Ulcer Index

SHEL:

6.17%

VRTX:

8.32%

Daily Std Dev

SHEL:

17.27%

VRTX:

24.56%

Max Drawdown

SHEL:

-67.46%

VRTX:

-91.77%

Current Drawdown

SHEL:

-8.85%

VRTX:

-20.34%

Fundamentals

Market Cap

SHEL:

$199.82B

VRTX:

$106.01B

EPS

SHEL:

$4.92

VRTX:

-$1.89

PEG Ratio

SHEL:

2.53

VRTX:

1.08

Total Revenue (TTM)

SHEL:

$218.03B

VRTX:

$8.09B

Gross Profit (TTM)

SHEL:

$37.19B

VRTX:

$6.99B

EBITDA (TTM)

SHEL:

$46.39B

VRTX:

-$699.50M

Returns By Period

In the year-to-date period, SHEL achieves a 5.20% return, which is significantly higher than VRTX's 2.22% return. Over the past 10 years, SHEL has underperformed VRTX with an annualized return of 5.25%, while VRTX has yielded a comparatively higher 12.90% annualized return.


SHEL

YTD

5.20%

1M

3.73%

6M

-7.49%

1Y

7.56%

5Y*

6.60%

10Y*

5.25%

VRTX

YTD

2.22%

1M

-11.23%

6M

-15.81%

1Y

-5.02%

5Y*

11.87%

10Y*

12.90%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

SHEL vs. VRTX — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SHEL
The Risk-Adjusted Performance Rank of SHEL is 6363
Overall Rank
The Sharpe Ratio Rank of SHEL is 6767
Sharpe Ratio Rank
The Sortino Ratio Rank of SHEL is 5656
Sortino Ratio Rank
The Omega Ratio Rank of SHEL is 5656
Omega Ratio Rank
The Calmar Ratio Rank of SHEL is 7171
Calmar Ratio Rank
The Martin Ratio Rank of SHEL is 6464
Martin Ratio Rank

VRTX
The Risk-Adjusted Performance Rank of VRTX is 3636
Overall Rank
The Sharpe Ratio Rank of VRTX is 4040
Sharpe Ratio Rank
The Sortino Ratio Rank of VRTX is 3333
Sortino Ratio Rank
The Omega Ratio Rank of VRTX is 3333
Omega Ratio Rank
The Calmar Ratio Rank of VRTX is 3737
Calmar Ratio Rank
The Martin Ratio Rank of VRTX is 3939
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

SHEL vs. VRTX - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Shell plc (SHEL) and Vertex Pharmaceuticals Incorporated (VRTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for SHEL, currently valued at 0.50, compared to the broader market-2.000.002.000.50-0.17
The chart of Sortino ratio for SHEL, currently valued at 0.76, compared to the broader market-4.00-2.000.002.004.000.76-0.07
The chart of Omega ratio for SHEL, currently valued at 1.10, compared to the broader market0.501.001.502.001.100.99
The chart of Calmar ratio for SHEL, currently valued at 0.53, compared to the broader market0.002.004.006.000.53-0.18
The chart of Martin ratio for SHEL, currently valued at 1.39, compared to the broader market0.0010.0020.001.39-0.51
SHEL
VRTX

The current SHEL Sharpe Ratio is 0.50, which is higher than the VRTX Sharpe Ratio of -0.17. The chart below compares the historical Sharpe Ratios of SHEL and VRTX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.000.501.001.502.00AugustSeptemberOctoberNovemberDecember2025
0.50
-0.17
SHEL
VRTX

Dividends

SHEL vs. VRTX - Dividend Comparison

SHEL's dividend yield for the trailing twelve months is around 4.18%, while VRTX has not paid dividends to shareholders.


TTM20242023202220212020201920182017201620152014
SHEL
Shell plc
4.18%4.39%3.76%3.48%3.78%5.44%6.14%5.48%4.79%5.88%6.98%4.72%
VRTX
Vertex Pharmaceuticals Incorporated
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Drawdowns

SHEL vs. VRTX - Drawdown Comparison

The maximum SHEL drawdown since its inception was -67.46%, smaller than the maximum VRTX drawdown of -91.77%. Use the drawdown chart below to compare losses from any high point for SHEL and VRTX. For additional features, visit the drawdowns tool.


-20.00%-15.00%-10.00%-5.00%0.00%AugustSeptemberOctoberNovemberDecember2025
-8.85%
-20.34%
SHEL
VRTX

Volatility

SHEL vs. VRTX - Volatility Comparison

The current volatility for Shell plc (SHEL) is 5.43%, while Vertex Pharmaceuticals Incorporated (VRTX) has a volatility of 13.73%. This indicates that SHEL experiences smaller price fluctuations and is considered to be less risky than VRTX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%12.00%14.00%AugustSeptemberOctoberNovemberDecember2025
5.43%
13.73%
SHEL
VRTX

Financials

SHEL vs. VRTX - Financials Comparison

This section allows you to compare key financial metrics between Shell plc and Vertex Pharmaceuticals Incorporated. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab